B Cell Prolymphocytic Leukemia

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies
Status:
Recruiting
Last Changed:
Nov 12, 2018
First Changed:
Oct 5, 2016
Disease(s):
B-cell Non-Hodgkins Lymphoma
Intervention(s):
XmAb13676
Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter’s Transformation and Leukemias
Status:
Completed
Last Changed:
Nov 26, 2013
First Changed:
May 14, 2007
Disease(s):
Richter's Transformation
Intervention(s):
OxaliplatinFludarabineCytarabineRituximabPegfilgrastim
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter’s Syndrome, Refractory CLL and PLL
Status:
Completed
Last Changed:
Nov 2, 2011
First Changed:
Mar 27, 2007
Disease(s):
Leukemia
Intervention(s):
CytarabineFludarabineOxaliplatinRituximab

Connect. Empower. Inspire.